Blood Levels Of C-Reactive Protein May Predict Heart Attack And Stroke Risk In Women As Well As Men

August 24, 1998

DALLAS, Texas, Aug. 25 -- Measuring C-reactive protein with a high sensitivity test may provide a powerful new method to predict risk of heart attack and stroke among healthy post-menopausal women, report researchers in today's Circulation: Journal of the American Heart Association.

According to the scientists, testing for this protein -- which is released into the bloodstream when the blood vessels leading to the heart are damaged -- adds to the predictive value of screening blood samples for both total and HDL (good) cholesterol levels. Thus C-reactive protein testing may improve doctors' ability to predict heart disease risk among women.

"C-reactive protein is a sensitive marker of inflammation, the process whereby the body responds to injury," says Paul M. Ridker, M.D., of Brigham and Women's Hospital and Harvard Medical School, Boston. "When we measure this protein with high-sensitivity test procedures, we seem to be able to detect how much underlying atherosclerosis a patient has and thus predict the risk of future heart attack and stroke events."

In the study, researchers measured C-reactive protein levels in blood samples obtained from participants in the Women's Health Study, an ongoing evaluation of 39,876 healthy, post-menopausal American women.

Overall, women with the highest levels of C-reactive protein had a five-fold increase in the risk of developing any cardiovascular disease and a seven-fold increase in risk of having a heart attack or a stroke, when compared to those with the lowest levels of C-reactive protein.

Levels of C-reactive protein predicted these events even among apparently low-risk women, such as those who did not smoke, had no evidence of high cholesterol and no family history of heart disease.

"These data confirm that increased levels of C-reactive protein are a strong marker of risk not only in middle-aged men, but also in healthy women," Ridker notes.

Last year Ridker and his colleagues reported in the Physicians' Health Study, an ongoing evaluation of 22,000 initially healthy men, that C-reactive protein was a potent predictor of heart attack risk.

"Taken together," he says. "these two studies provide hope that we can do a better job of identifying those at high risk for future heart disease."

In the study of women, levels of C-reactive protein were somewhat higher than previously found in men. The researchers suspect this may be because the women studied were more likely to smoke, weigh more and more likely to have high blood pressure and high cholesterol. It is also possible, they say, that there may be interactions between the inflammatory process and menopause itself.

The researchers caution that standard laboratory tests for C-reactive protein are not sufficient to determine cardiac risk.

"Physicians and their patients need to understand that only 'high-sensitivity' or 'ultrasensitive' tests for C-reactive protein are useful for this purpose," says Ridker. "Perhaps we should be calling this test 'Cardiac-CRP' rather than standard C-reactive protein."

The study was funded by the National Institutes of Health and the American Heart Association.

Co-authors are Julie E. Buring, Sc.D., and Charles H. Hennekens, M.D., of Harvard Medical School; and Jessie Shih, Ph.D., and Mathew Matias, B.S., of Abbott Laboratories, Abbott Park, Ill.
-end-


American Heart Association

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.